Israel - hebraisk - Ministry of Health

pfizer pharmaceuticals israel ltd - ceftiofur hydrochloride 50 mg / 1 ml - suspension for injection - infections associated with bacteria sensitive to ceftiofur: in pigs : for the treatment of bacterial respiratory disease associated with pasteurella multocida actinobacillus pleuropneumoniae adn streptococcus suis. in cattle : for the treatment of bacterial respiratory disease associated with mannheimia spp. (pasteurella haemolytica) pasteurella multocida and haemophilus somnus. for the treatment of acute interdigital necrobacillosis ( panaritium foot rot) associated with fusobacterium necrophorum adn bacteroides melaninogenicus (porphyromonas asaccharolytica). for treatment of the bacterial coponent of acute post-partum (puerperal) metritis within 10 days after calving associated with escherichia coli arcanobacterium pyogenes and fusobacteriu necrophorum sensitive to ceftiofur.

Israel - hebraisk - Ministry of Health

ש.שוורץ באר שבע בעמ - מניעת תפרחת חיתולים

Israel - hebraisk - Ministry of Health

"דין ציוד רפואי בע""מ" - אחר - "לשימוש במוסדות רפואיים מרפאות, בתי חולים ,בתי מרקחת ומוסדות סיעודיים"

Israel - hebraisk - Ministry of Health

דין ציוד רפואי - אחר - לשימוש במוסדות רפואיים מרפאות, בתי חולים ,בתי מרקחת ומוסדות סיעודיים

Israel - hebraisk - Ministry of Health

pfizer pharmaceuticals israel ltd - inotuzumab ozogamicin - אבקה להכנת תמיסה מרוכזת לעירוי - inotuzumab ozogamicin 1 mg/vial - inotuzumab ozogamicin

Israel - hebraisk - Ministry of Health

pfizer pharmaceuticals israel ltd - gemtuzumab ozogamicin - אבקה להכנת תמיסה מרוכזת לעירוי - gemtuzumab ozogamicin 5 mg/vial - gemtuzumab

Israel - hebraisk - Ministry of Health

pfizer pharmaceuticals israel ltd - bevacizumab - תרכיז להכנת תמיסה לאינפוזיה - bevacizumab 25 mg / 1 ml - bevacizumab

Israel - hebraisk - Ministry of Health

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 1000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob

Israel - hebraisk - Ministry of Health

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 2000 iu / 1 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob

Israel - hebraisk - Ministry of Health

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 30000 iu / 0.75 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob